jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Pharmacy PracticeNOW IN
Review

Hematologic Manifestations in Systemic Lupus Erythematosus: A Systematic Review of Clinical Patterns, Prognostic Implications, and Epidemiology

Abdullah Al-Sheef1, Luluh Khalid2, Raneem Almutairi3, Renad Alhajlah4, Nora Alotaibi5, Shaden Almutairi4, Abdullah Hamdan6, Khalid Al-Moqader7, Amjad Al-Moqader8, Shahad Alelaiw9, Maryam Alfehaid10, Maha Alfayad10, Sarah Jabbari11, Wasan Alenazi12, Abdullah Shaher13

  1. 1Department of Nursing, University of Hafr Al Batin, Saudi Arabia.
  2. 2College of Medicine, Hail University, Hail, Saudi Arabia.
  3. 3Department of Pharmacy, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  4. 4College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  5. 5College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  6. 6College of Pharmacy, Northern Border University, Rafha, Saudi Arabia.
  7. 7College of Radiology, University of Najran, Najran, Kingdom of Saudi Arabia.
  8. 8College of Pharmacy, University of Abha, Abha, Kingdom of Saudi Arabia.
  9. 9Imam Abdulrahman Bin Faisal University, Kingdom of Saudi Arabia.
  10. 10College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Kingdom of Saudi Arabia.
  11. 11Faculty of Pharmacy, Jazan University, Jazan, Saudi Arabia.
  12. 12Department of Pharmacy, Northern Borders University, Rafha, Saudi Arabia.
  13. 13College of Pharmacy, Northern Border University, Rafha, Saudi Arabia.

Received: 11-03-2025; Accepted: 01-05-2025.

Volume 23, Issue 4 · pp. 3179 · PUBLISHED Oct-Dec 2025 · DOI: 10.18549/PharmPract.2025.4.3179

View on PP original site ↗

ABSTRACT

Systemic lupus erythematosus (SLE) is a long-term autoimmune disease that has various clinical manifestations, the hematologic abnormalities among which are frequent and vary in clinical severity. These may cause simple cytopenias up to extreme autoimmune cytopenias, and significantly affect the activity of the disease, prognosis, and treatment. The proposed systematic review is expected to synthesise existing data on the prevalence, clinical features, and prognostic consequences of hematologic involvement in patients with SLE in children and adults. The studied data were searched in PubMed, PMC, WHO IMSEAR, and other databases to find publications published in 2025. They included observational studies, cohort studies, cross-sectional studies and reviews that were relevant. Information was coming out on the hematologic parameters, the occurrence of cytopenias, disease-related activity, autoantibody profiles, and the presence of splenomegaly. The inclusion studies were evaluated by the Newcastle-Ottawa Scale to assess quality, and the PRISMA was used to report them. Among the studies that were included, hematologic abnormalities that were most common were anaemia, leukopenia, and thrombocytopenia, though autoimmune hemolytic anaemia and immune thrombocytopenia occurred in a subset of patients. Guidelines showed that the incidence of cytopenias was high in pediatric populations, in contrast with adults. Hematologic aberrations were often related to augmented disease activity, involvement of the kidneys, and the presence of autoantibodies. Splenomegaly, being less prevalent, showed an association with bad cytopenias and poor prognosis across various cohorts. Hematologic presentations are inherent parts of SLE and have both diagnostic, prognostic, and treatment ramifications. Early detection and surveillance of the hematologic involvement can promote person-specific management approaches, enhance the outcomes, and guide future research topics related to the pathogenesis of the disease and targeted therapies.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Al-Sheef, A., Khalid, L., Almutairi, R., Alhajlah, R., Alotaibi, N., Almutairi, S., Hamdan, A., Al-Moqader, K., Al-Moqader, A., Alelaiw, S., Alfehaid, M., Alfayad, M., Jabbari, S., Alenazi, W., & Shaher, A. (2025). Hematologic Manifestations in Systemic Lupus Erythematosus: A Systematic Review of Clinical Patterns, Prognostic Implications, and Epidemiology. Pharmacy Practice, 23(4), 3179. https://doi.org/10.18549/PharmPract.2025.4.3179